Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Indian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...

Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...

India faces a strong El Niño, threatening below-normal rainfall and impacting agriculture. While rural-linked sectors like two-wheelers and...

Our technical analysts identify select stocks on every trading day that may gain momentum even in volatile markets. Here are the technical ...

Indian markets are set for a dynamic start today. Investors will closely watch the Q4 results from banking giants HDFC Bank and ICICI Bank....

Indian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...

JioBlackRock Mutual Fund’s Flexi Cap Fund exited Swiggy and 20 other stocks in March, while adding ICICI Prudential Asset Management Compan...

Markets experienced a sharp sell-off on Monday's monthly expiry day, with the Nifty closing near 22,331. Key companies like IndiGo, Bharti ...

Lupin Ltd, a pharma stock, has broken out of a 7-month consolidation, signaling a potential bull comeback. Experts suggest short-term trade...

Earlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 manufacturing facili...

Lupin, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 49542.29 Crore) operating in Pharmaceuticals sector.

Lupin’s daily trend is bullish, however, in the last few trading sessions, it is showing weaknesses. In the last trading session, it closed...